Virovance
Virovance is a biotechnology company focused on developing AI-driven small molecule therapies that target difficult-to-treat cancers by inhibiting cyclin-dependent kinases (CDKs). They leverage predictive modeling, cheminformatics, and in silico screening, powered by their proprietary AI engine ViroCoreAI, to rapidly discover and optimize novel drug candidates. Their approach combines AI-enabled compound discovery, structure-guided design, and ADMET/drug-likeness filtering to identify and optimize leads with high precision.
Virovance
Virovance is a biotechnology company focused on developing AI-driven small molecule therapies that target difficult-to-treat cancers by inhibiting cyclin-dependent kinases (CDKs). They leverage predictive modeling, cheminformatics, and in silico screening, powered by their proprietary AI engine ViroCoreAI, to rapidly discover and optimize novel drug candidates. Their approach combines AI-enabled compound discovery, structure-guided design, and ADMET/drug-likeness filtering to identify and optimize leads with high precision.